Dermatology Doctors in Cheyenne, WY Accepting Medicare

7 Dermatology doctors found. Showing 1 - 7

Krystal J Massey, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 123 Western Hills Blvd, Cheyenne, WY 82009 Phone: 307-635-0226

Dr. Julie A Neville, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 123 Western Hills Blvd, Cheyenne, WY 82009 Phone: 307-635-0226    Fax: 307-635-1924

Dr. Mary O Cole, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 123 Western Hills Blvd, Cheyenne, WY 82009 Phone: 307-635-0226    Fax: 307-635-1924

Dr. Kathleen A Thomas, MD Dermatology - Pediatric Dermatology Medicare: Accepting Medicare Assignments Practice Location: 123 Western Hills Blvd, Cheyenne, WY 82009 Phone: 307-635-0226    Fax: 307-635-1924

Larry E Seitz, MD Dermatology - Dermatopathology Medicare: Not Enrolled in Medicare Practice Location: 2112 Seymour Ave, Cheyenne, WY 82001 Phone: 307-635-8299    Fax: 307-635-6984

Dr. Sandra K Surbrugg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 123 Western Hills Blvd, Cheyenne, WY 82009 Phone: 307-635-0226    Fax: 307-635-1924

Mr. Christian B Anderson, D.O. Dermatology - MOHS-Micrographic Surgery Medicare: Medicare Enrolled Practice Location: Cheyenne Skin Clinic, 123 Western Hills Blvd., Cheyenne, WY 82009 Phone: 307-635-0226    Fax: 307-635-1924

News Archive

Vaccines in the Aging Population

The World Health Organisation marked World Pneumonia Day on November 12th to promote interventions to protect against, prevent and treat pneumonia. The condition is a worldwide killer affecting people of all ages, however the ‘aging population' is at an increased risk.

UCLA researchers develop new method to rapidly measure cell's stiffness and size

UCLA biophysicists have developed a new method to rapidly determine a single cell's stiffness and size - which could ultimately lead to improved treatments for cancer and other diseases.

MGH-CEM researchers develop microfabricated device to analyze effects of pro-drugs on cancer cells

A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine has developed a novel approach that dramatically simplifies the evaluation of the liver's drug-metabolizing activity and the potential toxic effects of the products of that activity on other organs.

Pluristem advances toward PLX-PAD Phase IIb clinical trials for CLI and Moderate-severe Claudication

Pluristem Therapeutics Inc. today announced that following its meeting with the Paul Ehrlich Institute (PEI), the German regulatory authority for advanced therapy products (ATP), the company is advancing toward designing two Phase IIb clinical trials for its placenta-derived cell therapy product, PLX-PAD, for the treatment of Critical Limb Ischemia (CLI) and Moderate-severe Claudication.

Read more Medical News

› Verified 5 days ago